AG14133
Endothelial from Vein, umbilical
Description:
APPARENTLY HEALTHY INDIVIDUAL
|
Repository
|
NIA Aging Cell Culture Repository
|
| Subcollection |
Apparently Healthy Collection |
|
Biopsy Source
|
Vein, umbilical
|
|
Cell Type
|
Endothelial
|
|
Tissue Type
|
Vein
|
|
Transformant
|
Untransformed
|
|
Sample Source
|
Endothelial from Vein, umbilical
|
|
Relation to Proband
|
proband
|
|
Confirmation
|
Clinical summary/Case history
|
|
ISCN
|
46,X,-Y,del(2)(qter>p16:),add(5)(pter>q31::?),+mar[2]/92,XXYY[15]/46,XY[33]
|
|
Species
|
Homo sapiens
|
|
Common Name
|
Human
|
|
Remarks
|
|
| PDL at Senescence |
23 |
| Passage Frozen |
4 |
| |
| IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase, Glucose-6-Phosphate Dehydrogenase, and Lactate Dehydrogenase Isoenzyme Electrophoresis |
| |
| Remarks |
Culture established from normal full-term umbilical cord vein. The culture was initiated on 1/30/1996 by canulating the vein, flushing with saline and collecting the cells released from the lumen by collagenase digestion. The culture was grown on gelatin-coated flasks and the medium was supplemented with 0.05mg/ml crude ECGF and 0.05mg/ml heparin. Cells were frozen in growth medium containing 7.5% polyvinylpyrrolidinone and 5% DMSO.This culture tested positive for the endothelial cell-specific von Willebrand factor and negative for alpha-smooth muscle actin (immunofluorescence assays). The culture is a mosaic with karyotype: 46,X,-Y,del(qter>p16:),add(5)(pter>q31::?),+mar[2]/92,XXYY[15]/46,XY[33] The legacy karyotype description shown in this Remark may not be representative of the current available product. |
| PDL at Senescence |
23 |
| Passage Frozen |
4 |
| Split Ratio |
1:4 |
| Temperature |
37 C |
| Percent CO2 |
5% |
| Percent O2 |
AMBIENT |
| Medium |
Medium 199 in Earl BSS with 2mM L-glutamine or equivalent |
| Serum |
15% fetal bovine serum Heat Inactivated |
| Substrate |
Gelatin |
| Subcultivation Method |
trypsin-EDTA |
| Supplement |
Endothelial Cell Growth Supplement 0.02 mg/ml |
| Supplement |
Heparin 0.05 mg/ml |
|
|